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Abstract This study evaluated the protective effects of
Noni fruit juice on acute liver injury induced by carbon
tetrachloride (CCl4) in female Sprague-Dawley (SD) rats.
Liver damage (micro-centrilobular necrosis) was observed
in animals pretreated with 20% placebo (drinking water) +
CCl4. However, pretreatment with 20% Noni juice in
drinking water + CCl4 resulted in markedly decreased
hepatotoxic lesions. Furthermore, serum alanine amino-
transferase and aspartate aminotransferase levels were
significantly lower in the Noni group than the placebo
group. In a correlative time-dependent study, one dose of
CCl4 (0.25 mL/kg in corn oil, p.o.) in female SD rats,
pretreated with 10% placebo for 12 days, caused sequential
progressive hepatotoxic lesions over a 24 h period, while
a protective effect from 10% Noni juice pretreatment was
observed. These results suggest that Noni juice is effective
in protecting the liver from extrinsic toxin exposure.
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Abbreviations
ALT alanine aminotransferase
AST aspartate aminotransferase
CCl4 carbon tetrachloride
H & E hematoxylin and eosin
LM light microscope
LPO lipid peroxide
SAR superoxide anion radical
TNJ Tahitian Noni® Juice
Introduction
Carbon tetrachloride (CCl4) is a common environmental
pollutant and liver carcinogen. Due to its detoxifying
function in protecting the body, the liver is a target for
CCl4 toxicity [1]. Antioxidants and anti-inflammatory
agents play a critical role in liver protection by scavenging
superoxide anion radicals (SAR) and neutralizing lipid
peroxides (LPO). They also suppress the inflammatory
response [2–4]. Therefore, there is need for a natural
product that protects the liver, but is also cost-effective
and safe, without long-term side effects. This study
evaluated the liver protective potential of the fruit juice of
Morinda citrifolia (Noni), from Tahiti, a strong antioxidant
and anti-inflammatory nutritional supplement.
We have previously reported that Noni juice is an
effective antioxidant, demonstrating a dose-dependent
effect against SAR and LPO in vitro [5]. Based on the data
from our laboratory and others, we suggested that Noni
juice may be effective in protecting the liver against acute
CCl4 toxicity. To test our hypothesis, a classic CCl4-induced
liver injury model was chosen to study the liver protective
effect in female SD rats. Morphological change is the most
direct sign of liver injury. Histopathological changes were
evaluated for morphological evidence of the liver protective
properties of Noni juice. Serum alanine aminotransferase
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Provo, UT 84604, USA(ALT) and aspartate aminotransferase (AST) assays that
measure liver function were performed on the Noni group
(Noni + CCl4) and compared to those of the positive control
group (placebo + CCl4).
Materials and Methods
Materials
Carbon tetrachloride was purchased from Sigma Chemical
Co., St. Louis, MO, USA. Noni juice was made by Morinda
Holdings Inc. (Provo, UT, USA) from Noni fruit originating
in Tahiti. The placebo was prepared using the same
procedures and ingredients for making Tahitian Noni®
Juice (TNJ), but without the Noni component.
Animals
Six-week-old female SD rats were purchased from Charles
River Inc. (Wilmington, MA, USA). The animals were
housed in a room maintained at 25 °C with a 12 h
photoperiod. They were fed a laboratory chow diet and
water ad libitum. The experimental design for these tests
was approved by the Institutional Ethics Review Commit-
tee for animal experiments at the National Cancer Center.
Experiment 1
Animal Treatment
Sixteen female SD rats were divided into two groups of
eight each. Both groups were provided drinking water for
7 days. Twenty percent placebo was added to the drinking
water in one group and 20% Noni juice in the other. On
day 8, four animals from each group were fed 0.5 mL/kg
CCl4 in corn oil. All animals were sacrificed at 6 h post-
CCl4 administration. The liver was removed and fixed in
10% neutral formalin for histological examination. Blood
was collected from each animal for serum AST and ALT
activity to examine liver function.
LM Examination
Liver samples were preserved in 10% neutral buffered
formalin and dehydrated in a graded alcohol series.
Following xylene treatment, the specimens were embedded
in paraffin blocks and cut into 5 μm thick sections.
Consecutive sections were stained with hematoxylin and
eosin (H & E) and examined under an Olympus BH2 light
microscope. The number of foci/mm
2 was counted to assess
the degree of necrosis [6]. Digital images were recorded
with the Pixera Visual Communication Suite.
Fig. 1 H & E liver sections
(250X), from female SD rats
showing protective effect of
20% Noni pretreatment d on
acute hepatotoxicity at 6 h post-
CCl4 exposure (0.5 mL/kg CCl4
in corn oil). The rats in
a (control) and b (noni treated)
received no CCl4 exposure, and
show no signs of liver-cell
damage. With CCl4 exposure,
there are significant hepatotox-
icity effects: balloon liver cells
and apoptotic necrotic cells ad-
jacent to the central vein
(arrow and arrowhead (c)).
d In contrast, with Noni
pretreatment + CCl4 exposure,
shows no signs of hepatotoxici-
ty. b and d (noni treated) show
cell patterns that are more or-
dered, and show no signs of
hepatotoxicity
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Serum was separated from clotted blood by centrifugation
at 1,600 rpm for 10 min at 4 °C. Serum ALT and AST
activities were measured using an automatic biochemical
analyzer calibrated with quality control standards (E.I. du
Pont de Nemours) in a clinical laboratory (Family Medicine
Laboratory, UIC College of Medicine at Rockford).
Experiment 2
Animal Treatments
Thirty-six female SD rats were divided into two groups of 18
each. While dose range-finding experiments revealed that
maximum protection occurred with 20% Noni juice in
drinking water, optimum protection (per amount ingested)
occurred with 10%. Therefore, each group was supplied 10%
placebo or 10% Noni juice in drinking water for 12 days. On
day 13, 15 animals from each group were fed 0.25 mL/kg
CCl4 in corn oil. Three animals from each group were
sacrificed at 1, 3, 6, 16, and 24 h post-CCl4 administration.
The remaining three animals in each group were fed 1 mL/kg
corn oil and sacrificed 1 h later, to serve as vehicle placebo
and Noni controls. Multiple liver-tissue samples were
removed from each rat to be fixed for LM examination.
LM Examination
Liver samples for experiment 2 were prepared and observed
for light microscopy as described in experiment 1.
Statistical Analysis
Statistical analysis was done by a Student two-tail T test
[7]. Differences were considered as significant at P<0.05
and highly significant at P<0.01. Results were expressed as
mean ± SD.
Fig. 2 Rat liver sections
(100×), showing representative
sequential hepatopathology at 3,
6, or 16 h following pretreat-
ments with 10% Noni juice, or
placebo, plus 0.25 mL/kg CCl4.
Panels: a 3 h post-CCl4 + Noni
juice (normal hepatic structure);
b 3 h post-CCl4 + placebo, (first
stages of hepatocyte swelling
pericentral to vein; arrow
denotes swollen hepatocytes);
c 6 h post-CCl4 + Noni (normal
hepatic structure); d 6 h post-
CCl4 + placebo, (increased
number and degree of swollen
hepatocytes); e 16 h post-CCl4 +
Noni (balloon cells adjacent to
pericentral vein, and delayed
response of hepatotoxicity); and
f 16 h post-CCl4 + placebo
(increase in number of damaged
foci, and an extension of dam-
aged area midzonal to vein;
arrow indicate swollen hepato-
cytes, arrowhead denotes
inflammatory foci)
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In experiment 1, the liver lobular structure among rats treated
6 h earlier with 20% placebo or 20% Noni juice did not reveal
any noticeable histological changes (Fig. 1a,b), which
indicates that high-dose pretreatment with Noni juice or
placebo does not produce hepatotoxicity. Hepatic sections,
from rats pretreated with 20% placebo followed by CCl4
treatment, showed typical CCl4-induced liver injury
(Fig. 1c). Sections revealed extremely vacuolized hepato-
cytes (balloon liver cells and apoptotic necrotic cells)
adjacent to the central vein (arrows and arrowhead,
Fig. 1c), indicating acute CCl4-induced hepatotoxicity.
Hepatocytes were significantly protected from CCl4-induced
toxicity by 20% Noni juice pretreatment (Fig. 1d), and
demonstrated a normal appearance, except for slight steatosis
(fatty deposition) in hepatocytes pericentral to the vein. In the
CCl4 + 20% placebo group, 23.8% of cross-sectional areas
contained swollen balloon cells, whereas in the CCl4 +2 0 %
Noni group, only 1.9% contained vacuolized cells (P<0.001).
Furthermore, the apoptotic cells were dramatically decreased
by 50% in the Noni pretreated group when compared with the
CCl4 + placebo group (P<0.001).
In experiment 2, 10% Noni + CCl4 pretreatment resulted
in a delayed appearance of damaged hepatocytes with a
significantly decreased number of necrotic foci (80%) and
apoptosis (50%), compared to the placebo group at 3, 6,
and 16 h (arrows and arrowhead, Fig. 2b,d,f). These results
indicate that Noni juice protects the liver from acute CCl4
exposure. Cellular damage consisted of vacuolated hepato-
cytes and inflammatory cells surrounding the central vein in
the placebo + CCl4 group (Fig. 2b,d,f). Conversely, liver
lobules in the Noni juice + CCl4 group maintained a normal
appearance in each of the post-treatment time intervals
(Fig. 2a,c,e).
Comparative histopathological changes of the Noni juice
and placebo-treated groups, at 3 h post-0.25 mL/kg CCl4
treatment, are shown in Fig. 3. The effects of 10% Noni
juice on reducing inflammation surrounding the central vein
area (Fig. 3a), and the absence of swollen hepatocytes are
clearly shown in the H & E sections. In Fig. 3b, a similar
liver section from the CCl4 + 10% placebo treatment
reveals swollen hepatocytes and a massive influx of
inflammatory cells (arrow and arrowheads, Fig. 3a,b).
Noni Juice Suppresses ALT and AST Activities
Serum ALT and AST activities were determined for
enzymatic evidence of liver injury (Table 1). The protective
effect of Noni juice against CCl4-induced hepatotoxicity
was demonstrated by a significant 50% suppression (P<
0.05) of ALT activity compared to the placebo. AST
activity in the Noni juice pretreated group was significantly
suppressed by 68% (P<0.01), compared to the placebo. As
noted in the table, the 20% placebo or 20% Noni juice in
drinking water for 7 days did not influence liver function
compared with the control. In contrast, the 20% placebo +
CCl4 treatment produced acute liver damage as measured
by elevated serum ALT and AST activities.
The present study supports the protective effects of Noni
juice on acute CCl4-induced hepatotoxicity. Necrosis of
hepatocytes was minimized in livers of animals pretreated
with Noni juice in both experiments. Noni juice prevented
free-radical-induced oxidative-pathological events.
Damaged hepatocytes release ALT and AST enzymes
following acute exogenous toxin exposure. Therefore these
elevated serum enzyme levels are good chemical indicators of
liver damage. Nonijuiceisable to normalizeliverfunctionafter
Fig. 3 H & E cross sections
(150×), of pericentral vein areas
showing inhibitory effect of
10% Noni juice on inflammation
at 3 h post-0.25 mL/kg
CCl4-induced acute hepatotox-
icity (a), versus placebo + CCl4
(b). Arrows denote increased
foci of inflammatory cells,
arrowheads indicate swollen
hepatocytes
Table 1 Effect of Noni juice on acute CC14-induced hepatitis in SD
rats
Treatment ALT (IU/L) AST (IU/L)
Control 67±31
** 222±121
**
Placebo (20%) 67±26
** 222±99
**
Noni juice (20%) 65±59
** 184±31
**
Placebo (20%) + CCl4 0.5 mL/kg
a 136±41 1135±466
Noni juice (20%) + CCl4 0.5 mL/kg 68±12
** 358±69
*
aData from each group were compared to that of the positive control
group (20% placebo + 0.5 mL/kg CC14). Data are expressed as means
±S D( n=4). Student two-tail T test
*P<0.05,
**P<0.01
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measure of defense enzyme levels, was significantly sup-
pressed after CCl4 exposure in the Noni juice pretreated
animals, compared with the elevated enzyme levels in the
placebo pretreated animals. Therefore, pretreatment with Noni
juice indeed protected hepatocytes from acute CCl4 exposure.
A few reports have suggested the involvement of Noni
juice in the development of chemically induced hepatitis in
a limited number of cases in Europe. However, no causal
role has been established in any of these instances. Further,
an official European investigation of these cases determined
that no relationship between Noni juice and hepatitis was
evident and that consumption of Noni juice is unlikely to
induce adverse human liver effects [8]. Animal and human
studies have revealed that Noni juice is not hepatotoxic,
even at very high doses [9, 10].
Conclusions
Our investigation suggests that Noni juice exerts effective
protection against acute extrinsic chemical induced hepatic
injury by inhibiting inflammatory response and suppressing
elevated liver enzyme activities; thus preventing conse-
quent cell membrane damage. Histopathological observa-
tions revealed morphological evidence, and bioassays
revealed functional evidence, that Noni confers resistance
to acute CCl4-induced hepatotoxicity. High dosages of Noni
and placebo pretreatments did not induce liver damage.
Noni may thus be an efficacious natural hepatoprotective
nutritional supplement against chemically induced hepato-
toxicity. Future studies should focus on how Noni juice
influences the inflammatory and cytotoxic cytokines in-
volved in liver injury.
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